News

Patient must give explicit consent Request for permission to use medical data, leftover human biomaterial and images

MyCoS sub-biobank

The Radboud Biobank has added one new sub-biobank to the collection: MyCoS.

LUMO Labs and Oost NL invest in Aiosyn Investment accelerates development of artificial intelligence platform to improve diagnostics

Aiosyn, a spin-off from Radboudumc, has received an investment from LUMO Labs. Oost NL is a co-investor.

DeepRank: a deep learning framework for data mining 3D protein-protein interfaces

Li Xue and colleagues recently published ''DeepRank, a deep learning framework for data mining 3D protein-protein structures'' in Nature Communications.

Dutch-Nordic Alliance for Precision Cancer Medicine launched

The Nordic countries (Denmark, Sweden, Norway, and Finland) are together setting up national clinical precision cancer trials modelled on the very successful DRUP trial in the Netherlands.

AI for Health course open for applications

Have you ever thought about exploring and understanding the field of artificial intelligence? Due to the successes in past years, another AI for Health course will be held in 2022. The deadline for application is 17 December 2021, so make sure to reserve a spot!

Dutch institutions sign agreement about their research using animals

Radboudumc, Radboud University and 13 other organisations involved in animal testing in the Netherlands have signed the Dutch Transparency Agreement on Animal Testing. The institutes commit themselves to communicate in a more open way about how animals are used in research.

Large AI project receives over €95 million for ten years of public-private research

The Dutch Research Council (NWO) is to fund two consortia for a period of ten years. Radboudumc participates in the ROBUST consortium, which consists of 17 AI labs, eight of which are dedicated to healthcare. Radboudumc leads five of these eight labs.

New Automated PBMC isolation method introduced in LMI.

The Radboud Biobank (RB) and the laboratory of Medical Immunology (LMI) are making plans to replace the density gradient centrifugation method with a new automated PBMC isolation method, the AutoMACS Pro Separator.

Health-RI, geared up to accelerate

The Dutch cabinet has selected Health-RI's National Growth Fund proposal for a national health data infrastructure. On 5 October, the kick-off will take place during a live meeting in Jaarbeurs Media Plaza in Utrecht.

SUNRISE-CRC sub-biobank

The main purpose of SUNRISE-CRC is to determine whether treatment with a high dose of sunitinib provides a better chance of survival and slows the progression of (colo)rectal cancer (CRC) more than standard treatment with TAS-102.

PRECISE sub-biobank

The aim of the PRECISE biobank is to develop the first, smart multi-modal liquid biopsy test service for the prediction of immune checkpoint inhibitor response in urothelial cancer (UC) patients – the PRECISE IVD.

Lysine Metabolism sub-biobank

Hereditary metabolic disorders form a large group of more than 1,400 rare disorders in which an error in the DNA causes abnormalities in the process in which proteins, fats and carbohydrates are converted into smaller building materials and energy.

Hyperintense sub-biobank

Cerebral small vessel disease (SVD), encompasses a collection of pathologies that affect the smallest blood vessels in the brain.

Duchenne Muscular Dystrophy Parel

Duchenne muscular dystrophy (DMD) is a rare X-linked hereditary disorder (locus Xp21.2) and therefore occurs almost exclusively in boys.

ADOPT sub-biobank

In the multicenter clinical study ADOPT, 280 men with oligo-recurrent prostate cancer from 10 participating hospitals in the Netherlands are randomized to receive standard metastasis-targeted radiotherapy or metastasis-targeted radiotherapy in combination with 6 months of ADT.

Myotonic Dystrophy sub-biobank

Myotonic Dystrophy is an autosomal dominantly inherited multisystem disorder (MD type 1 and MD type 2).

Radboud Biobank Oncology

The Radboud Biobank Oncology stores biomaterial (plasma, serum, cfDNA, tumor tissue) from patients with a proven malignancy or a high suspicion of malignancy, together with data about the patient's disease course.

New start-up Patholyt will bring AI research into pathology diagnostics

Patholyt is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. Patholyt is a spin-off from Radboudumc, a frontrunner in computational pathology research.

Cooperating T cells clear tumor cells more effectively

Live imaging: immune cells attack tumor

Nijmegen literally puts Digital Health on the map Flourishing ecosystem gets its own interactive overview

Digital Health is thriving in the Nijmegen region, where it contributes to better care and health and also creates jobs. To bring developers and end users even closer together, The Economic Board and the Radboudumc are introducing the Interactive Digital Health map.

Next Generation cytogenetics is on its way Does Optical Genome Mapping turn cytogenetics upside down?

Dutch-French research shows that Optical Genome Mapping (OGM) detects abnormalities in chromosomes and DNA very quickly, effectively and accurately.

Vooijs award for Merel van der Stelt

Merel van der Stelt has won the Vooijs Award with her final research project 'Making prosthetic devices' in the 3D lab at the Masanga Hospital in Sierra Leone. This award goes to the most clinically relevant final research project in the Technical Medicine educational programmes in the Netherlands.

First volunteers vaccinated with Radboudumc malaria vaccine

Today a new vaccine against malaria, largely developed in Nijmegen, is being tested for the first time in volunteers at Radboudumc.

Overview of samples in storage

It is possible to request an overview of the samples stored in a sub-biobank when desired.

Magazine celebrating 10 years BBMRI.nl

In the past 10 years, BBMRI.nl has made great progress in fulfilling its mission to maximize the use of biomaterial, images and clinical data for health research.

Growth Fund invests in Health-RI proposal for health data infrastructure

The Dutch Government has decided to honor Health-RI's proposal for a national health data infrastructure.

GENPAD sub-biobank

The GENPAD Biobank is part of the GENPAD study and contains biomaterial and clinical data from patients with peripheral arterial disease.

CORONIS sub-biobank

The CORONIS Biobank will focus on research into the pathophysiology of ischemic stroke after COVID-19 infection.

Vici grant for Michiel Vermeulen Reading the epitranscriptome

Michiel Vermeulen, theme Cancer development and immune defense, has been awarded a Vici grant from the Netherlands Organisation for Scientific Research (NWO), one of the largest personal scientific awards in the Netherlands.

Miljoenen voor kennis- en investeringsconsortium op het gebied van AI

Een kennis- en investeringsconsortium met het Radboudumc heeft acht miljoen euro subsidie gekregen om innovatie op het gebied van Artificial Intelligence (AI) versneld naar de markt te brengen.

Genetic patch 'inhibits' blindness in patients with Usher syndrome Leiden-based ProQR expands Radboudumc research further

Biotech company ProQR Therapeutics presented positive results from a phase I/II clinical trial with the molecule QR-421a. This molecule was in its earliest stages developed by researchers at Radboudumc.

Current overview of intriguing RNA therapies

In an article in EMBO Molecular Medicine, researchers from Radboudumc, together with European colleagues, provide an up-to-date overview of the (im)possibilities of these intriguing RNA therapies.

Framework for standards and assessment of accessing identifiable patient data for medical scientific research

A Framework for standards and assessment of accessing identifiable patient data for medical scientific research has been developed in the Radboudumc.

Animation Radboud Biobank for patients

The Radboud Biobank has had an animation made to inform Radboudumc visitors about the Radboud Biobank and its purpose.

HEALTH-RI Biobank Community

Biobanks are an indispensable part of the infrastructure for health research. That is why BBMRI.nl, Parelsnoer and Health-RI are joining forces.

RICH sub-biobank

Spontaneous intracerebral hematomas (ICH) are the most deadly form of stroke. The RICH biobank collects biomaterial (DNA, plasma, serum and PAXgene) from patients with spontaneous ICH.

SHM sub-biobank

Stichting HIV Monitoring’s (SHM) mission is to increase knowledge and understanding of all relevant aspects of HIV infection.

REGenG sub-biobank

The Radboud Expertise Center Sex & Gender (REG & G) is responsible for patient care, education, and research regarding gender incongruity / dysphoria.

Review of the Code of Conduct for Health Research

A public review of the full draft Code of Conduct is expected to occur in early 2021.

Assessment of research with material from an existing biobank.

If you want to perform research with material from a biobank and the initiation of this biobank has already been approved by the CMO Radboudumc, you only need to submit an application to the CMO Radboudumc for assessment in certain cases.

Sub-biobank MEMORY

The MEMORY biobank focuses on research into biomarkers for memory impairment and dementia and their validation in clinical cohorts.

RYR1 sub-biobank

The RYR1 biobank is part of a study of the neuromuscular and multisystem features of patients with malignant hyperthermia or rhabdomyolysis related to RYR1 (ryanodine receptor type 1) variants.

Sub-biobank CDG Congenital Disorders of Glycosylation

New colleague

My name is Robbert Croes and I started mid 2020 as a data-scientist at the Radboud Biobank.

ProBCI sub-biobank

There is a pressing need for predictive biomarkers to personalize bladder cancer treatment.

Financial regulation for sub-biobanks

Sub-biobanks are not required to pay up-front for the processing and storage of biomaterials. The effectiveness of this pre-financing agreement however is dependent on adherence to the demands regarding delivery and processing according to the Radboud Biobank standard operating procedures.

Software for ranking protein-protein interfaces Released by eScience Center

Li Xue of the CMBI contributed to the development of a software package that ranks and scores protein-protein interfaces (PPIs). This article was published in Software X.

Biobanking: the power of collecting

Urine, cerebrospinal fluid, blood. Everything is stored in Dutch biobanks. Collecting this takes a lot of time and money. Is it worth that? What does it yield?

Costs for internal researchers in case of request for samples

As of January 1, 2020, internal researchers who request samples from the Radboud Biobank will only be charged for the number of samples received.